These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10578605)

  • 21. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The V118I mutation as a marker of advanced HIV infection and disease progression.
    Zaccarelli M; Tozzi V; Lorenzini P; Forbici F; Narciso P; Ceccherini-Silberstein F; Trotta MP; Bertoli A; Liuzzi G; Marconi P; Mosti S; Perno CF; Antinori A
    Antivir Ther; 2007; 12(2):163-8. PubMed ID: 17503658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordant immunological and virological responses to antiretroviral therapy.
    Schechter M; Tuboi SH
    J Antimicrob Chemother; 2006 Sep; 58(3):506-10. PubMed ID: 16854959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical presentation, virological features, and treatment perspectives in primary HIV-1 infection.
    Perrin L; Yerly S
    AIDS Clin Rev; 1997-1998; ():67-92. PubMed ID: 9305444
    [No Abstract]   [Full Text] [Related]  

  • 25. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
    Marcello A; Giacca M
    Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in children.
    Saitoh A; Powell CA; Fenton T; Douglas SD; Starr SE; Fletcher CV; Spector SA
    J Infect Dis; 2004 Apr; 189(7):1216-20. PubMed ID: 15031790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy.
    Haubrich RH; Currier JS; Forthal DN; Beall G; Kemper CA; Johnson D; Dubé MP; Hwang J; Leedom JM; Tilles J; McCutchan JA;
    Clin Infect Dis; 2001 Oct; 33(7):1060-8. PubMed ID: 11528581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
    Rodriguez B; Woolley I; Lederman MM; Zdunek D; Hess G; Valdez H
    J Infect Dis; 2003 Feb; 187(3):504-7. PubMed ID: 12552436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary HIV infection.
    Perrin L
    Antivir Ther; 1999; 4 Suppl 3():13-8. PubMed ID: 16021866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular monitoring of human immunodeficiency virus type 1 infection.
    Clementi M; Bagnarelli P; Menzo S; Cardelli M; Mazzola F; Sampaolesi R
    J Biol Regul Homeost Agents; 1997; 11(1-2):64-8. PubMed ID: 9418166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary HIV-1 infection: a review of clinical manifestations, immunologic and virologic changes.
    Kaufmann GR; Duncombe C; Zaunders J; Cunningham P; Cooper D
    AIDS Patient Care STDS; 1998 Oct; 12(10):759-67. PubMed ID: 11362020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute primary HIV infection.
    Quinn TC
    JAMA; 1997 Jul; 278(1):58-62. PubMed ID: 9207340
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary HIV infection: clinical aspects and monitoring.
    Tambussi G; Lillo F; Capiluppi B; Clerici E; Gori A; Pietro MD; Gavazzeni G; Morandini B; Lazzarin A
    J Biol Regul Homeost Agents; 1997; 11(1-2):53-5. PubMed ID: 9418163
    [No Abstract]   [Full Text] [Related]  

  • 39. [Apoptosis and infection with the human immunodeficiency virus].
    Civatte M; Pierre C; Terrier JP; Calvet P; Carloz E
    Med Trop (Mars); 1999; 59(2):117-24. PubMed ID: 10546181
    [No Abstract]   [Full Text] [Related]  

  • 40. Not all is dead in HIV-1 graveyard.
    Grant RM; Abrams DI
    Lancet; 1998 Jan; 351(9099):308-9. PubMed ID: 9652607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.